Funding opportunities
100 live opportunities from Grants.gov, NIH, NSF, and more.
Physics & Astronomy× remove
- postedgrants.gov
- Title IV-E Prevention Accelerator GrantsAdministration for Children and Families - ACYF/CBHHS-2026-ACF-ACYF-CA-0061forecastedgrants.gov
- Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption AcceleratorCenters for Disease Control - NCCDPHPCDC-RFA-DP-26-0227forecastedgrants.gov
- Cell Type Specific Drug Repurposing for Alzheimer's DiseaseNational Institute on AgingPAR-25-374 closes 5/31/2031up to $1,419,145activenih
- Plasma Membrane Repair MechanismsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $775,022activenih
- Fli1 in Tfh Cell Differentiation and Humoral ImmunityNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $808,523activenih
- Investigating Mitochondrial DNA as a Biomarker and Therapeutic Target in Chronic Kidney DiseaseNational Institute of Diabetes and Digestive and Kidney DiseasesPA-24-175 closes 5/31/2031up to $148,596activenih
- Systemic Sclerosis Interstitial Lung Disease Risk Factors, Prediction, and Plasma Biomarker EvaluationNational Heart Lung and Blood InstitutePA-24-182 closes 5/31/2031up to $166,520activenih
- Targeting VIP–VPAC Signaling to Reverse Immune Exclusion and Enhance Immunotherapy Response in Pancreatic CancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $636,358activenih
- Perturbation of mammary immunoglobulins during maternal antibiotic administrationNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $836,132activenih
- HIV-1 Matrix and Envelope Protein InteractionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $708,281activenih
- From B-cell decisions to antibody repertoiresNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $744,483activenih
- The role of endogenous chimeric mRNA encoded GasderminD fusion proteins in immunityNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $794,886activenih
- Prospective Detection and Monitoring of NF1 peripheral nerve sheath tumors using cell-free DNANational Cancer InstitutePA-25-301 closes 5/31/2031up to $688,661activenih
- Neutralizing and FcR-mediating antibody specificities and function in control of HHV-8 infectionNational Institute of Allergy and Infectious DiseasesPAR-23-073 closes 5/31/2031up to $211,008activenih
- Spatial control of synthetic immunogenic cytotoxicity for the treatment of locally advanced lung cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $682,140activenih
- A novel chemical strategy to harness the tumor specific biochemistry of human kallikrein 2 for prostate cancer theranosticsNational Cancer InstitutePA-25-301 closes 4/30/2031up to $575,178activenih
- Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs Benzathine Penicillin in Neonates with Possible Congenital SyphilisNational Institute of Allergy and Infectious DiseasesPAR-24-100 closes 4/30/2031up to $2,336,069activenih
- The roles of P2RY8 in B cell tolerance and traffickingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-24-182 closes 4/30/2031up to $180,144activenih
- Translational and cross-species studies of the impact of cannabis use and HIV on mitochondrial homeostasis in brain macrophagesNational Institute on Drug AbuseRFA-DA-26-009 closes 4/30/2031up to $1,500,942activenih
- Investigating the development and contribution of individual plasma B cells to broad HIV serum neutralizationNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 4/30/2031up to $783,701activenih
- GENE ENVIRONMENT TRIGGERS AND PROTEOMIC PATHWAYS MEDIATING ANTI-NUCLEAR AUTOIMMUNITY AND SYSTEMIC RHEUMATIC DISEASENational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 4/30/2031up to $667,276activenih
- AI-enabled methods for de novo design of functional peptidesNational Institute of General Medical SciencesPAR-22-180 closes 3/31/2031up to $517,083activenih
- Exploring conformational and chemical spaces with advanced molecular simulation algorithmsNational Institute of General Medical SciencesPAR-22-180 closes 3/31/2031up to $593,975activenih
- MicroRNAs in neural-derived extracellular vesicles as biomarkers in first episode schizophreniaNational Institute of Mental HealthPA-25-305 closes 3/31/2031up to $795,165activenih
Page 1 of 4